5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME
申请人:Ajinomoto Co., Inc.
公开号:EP1020466A1
公开(公告)日:2000-07-19
The 5,11-dihydrodibenz[b,e][1,4]oxazepine derivatives represented by chemical formulae (1 and 2) and analogues thereof have a calcium channel antagonistic activity and are useful in the treatment or prevention of intestinal diseases such as gastrointestinal tract dyskinesia, in particular, irritable bowel syndrome.
化学式(1 和 2)代表的 5,11-二氢二苯并[b,e][1,4]氧氮杂卓衍生物及其类似物具有钙通道拮抗活性,可用于治疗或预防肠道疾病,如胃肠道运动障碍,特别是肠易激综合征。